X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1840) 1840
Publication (106) 106
Newsletter (37) 37
Book Review (33) 33
Book Chapter (26) 26
Book / eBook (16) 16
Newspaper Article (7) 7
Conference Proceeding (6) 6
Magazine Article (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1542) 1542
index medicus (800) 800
male (743) 743
female (710) 710
urology & nephrology (634) 634
chronic kidney disease-mineral and bone disorder - drug therapy (561) 561
middle aged (546) 546
chronic kidney failure (420) 420
adult (407) 407
aged (375) 375
parathyroid hormone - blood (374) 374
kidney failure, chronic - complications (359) 359
renal dialysis (356) 356
chronic kidney disease (340) 340
chronic kidney disease-mineral and bone disorder - etiology (330) 330
chronic kidney-disease (326) 326
hemodialysis (318) 318
secondary hyperparathyroidism (314) 314
kidney failure, chronic - therapy (312) 312
parathyroid hormone (303) 303
nephrology (302) 302
calcium - blood (296) 296
kidney diseases (294) 294
mortality (288) 288
vitamin d (277) 277
hemodialysis-patients (275) 275
risk factors (225) 225
vitamin d - therapeutic use (214) 214
calcium (213) 213
renal insufficiency, chronic - complications (203) 203
medicine & public health (195) 195
parathyroid-hormone (195) 195
child (194) 194
phosphorus - blood (192) 192
animals (191) 191
dialysis (188) 188
renal dialysis - adverse effects (187) 187
adolescent (184) 184
renal osteodystrophy (183) 183
treatment outcome (183) 183
hyperparathyroidism (181) 181
care and treatment (176) 176
hydroxycholecalciferols - therapeutic use (164) 164
vascular calcification (163) 163
chronic kidney disease-mineral and bone disorder - blood (160) 160
phosphates - blood (160) 160
chronic kidney disease-mineral and bone disorder - metabolism (159) 159
phosphates (159) 159
alkaline phosphatase - blood (157) 157
calcification (153) 153
hyperparathyroidism, secondary - drug therapy (153) 153
calcium - metabolism (152) 152
stage renal-disease (152) 152
dialysis patients (151) 151
hyperparathyroidism, secondary - etiology (151) 151
phosphorus (145) 145
analysis (143) 143
renal insufficiency, chronic - therapy (135) 135
kidney transplantation (133) 133
calcifediol (132) 132
osteoporosis (131) 131
research (131) 131
vitamin-d (131) 131
health aspects (129) 129
mineral metabolism (126) 126
calcitriol - therapeutic use (124) 124
alfacalcidol (122) 122
biomarkers - blood (120) 120
chronic kidney disease-mineral and bone disorder - pathology (120) 120
endocrinology & metabolism (119) 119
prospective studies (119) 119
patients (118) 118
bone and bones - metabolism (117) 117
phosphate (114) 114
bone and bones - pathology (112) 112
metabolism (112) 112
chronic kidney disease-mineral and bone disorder - physiopathology (111) 111
hyperphosphatemia (110) 110
kidney failure, chronic - blood (109) 109
medical research (107) 107
time factors (107) 107
chronic-renal-failure (106) 106
bone density (102) 102
bone diseases (102) 102
cardiovascular-disease (102) 102
physiological aspects (102) 102
renal insufficiency, chronic - blood (102) 102
calcitriol (100) 100
chronic kidney disease-mineral and bone disorder - diagnosis (100) 100
kidney failure, chronic - drug therapy (100) 100
chronic kidney disease-mineral and bone disorder - therapy (99) 99
aged, 80 and over (97) 97
medicine, experimental (97) 97
bone (96) 96
transplantation (95) 95
medicine, general & internal (93) 93
pediatrics (93) 93
renal insufficiency, chronic - drug therapy (93) 93
research article (93) 93
risk (93) 93
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1698) 1698
Japanese (53) 53
German (45) 45
Italian (28) 28
French (25) 25
Spanish (24) 24
Polish (12) 12
Russian (6) 6
Croatian (4) 4
Chinese (3) 3
Czech (3) 3
Danish (3) 3
Hebrew (3) 3
Dutch (2) 2
Slovak (2) 2
Korean (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2018, Volume 2018, Issue 8, p. CD006023
Background Phosphate binders are used to reduce positive phosphate balance and to lower serum phosphate levels for people with chronic kidney disease (CKD)... 
Bone Diseases | Metabolic [drug therapy | prevention & control]; Calcium [blood | JAPANESE HEMODIALYSIS-PATIENTS | Phosphorus [blood] | Calcium Compounds [adverse effects; therapeutic use] | RANDOMIZED CLINICAL-TRIAL | PERITONEAL-DIALYSIS PATIENTS | Parathyroid Hormone [blood] | Randomized Controlled Trials as Topic | Hypercalcemia [chemically induced] | MEDICINE, GENERAL & INTERNAL | PARATHYROID-HORMONE LEVELS | CORONARY-ARTERY CALCIFICATION | Polyamines [adverse effects; therapeutic use] | Sevelamer Humans | GROWTH-FACTOR 23 | ORAL FERRIC CITRATE | PLACEBO-CONTROLLED TRIAL | Kidney Diseases [blood; complications] | Chronic Disease | Chelating Agents [adverse effects; therapeutic use] | CHRONIC-RENAL-FAILURE | CALCIUM ACETATE/MAGNESIUM CARBONATE | Chronic Kidney Disease-Mineral and Bone Disorder - blood | Polyamines - adverse effects | Humans | Middle Aged | Polyamines - therapeutic use | Parathyroid Hormone - blood | Cause of Death | Sevelamer - therapeutic use | Calcium - blood | Calcium Compounds - adverse effects | Calcium Compounds - therapeutic use | Chronic Kidney Disease-Mineral and Bone Disorder - prevention & control | Adult | Iron Compounds - therapeutic use | Chelating Agents - therapeutic use | Iron Compounds - adverse effects | Lanthanum - adverse effects | Lanthanum - therapeutic use | Chelating Agents - adverse effects | Renal Dialysis - statistics & numerical data | Hypercalcemia - chemically induced | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Disease Progression | Phosphorus - blood | Aged
Journal Article
Kidney International, ISSN 0085-2538, 08/2006, Volume 70, Issue 4, pp. 771 - 780
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 10/2018, Volume 106, pp. 54 - 60
Chronic kidney disease-mineral and bone disorder (CKD-MBD) play a critical role in the pathogenesis of cardiovascular complications in patients with chronic... 
Zuogui pill | Chronic kidney disease | Nourish kidney | Mineral and bone disorder | Bone metabolism | MEDICINE, RESEARCH & EXPERIMENTAL | VITAMIN-D | DIURETIC ACTIVITY | VASCULAR CALCIFICATION | QUALITY-CONTROL | PORIA-COCOS | METABOLOMICS | METABOLISM | TRADITIONAL USES | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | CHRONIC-RENAL-FAILURE | Chronic Kidney Disease-Mineral and Bone Disorder - pathology | Chronic Kidney Disease-Mineral and Bone Disorder - blood | Kidney - pathology | Rats, Wistar | Chronic Kidney Disease-Mineral and Bone Disorder - physiopathology | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase - genetics | Drugs, Chinese Herbal - pharmacology | Parathyroid Hormone - blood | Bone Remodeling - drug effects | Bone and Bones - drug effects | Parathyroid Hormone - genetics | Sodium-Phosphate Cotransporter Proteins, Type IIa - metabolism | Calcium - blood | Kidney - metabolism | Bone and Bones - metabolism | Core Binding Factor Alpha 1 Subunit - blood | Kidney - physiopathology | Disease Models, Animal | Kidney - drug effects | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase - metabolism | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Sodium-Phosphate Cotransporter Proteins, Type IIa - genetics | Bone Density - drug effects | Bone and Bones - physiopathology | Animals | Fibroblast Growth Factors - blood | Phosphorus - blood | Creatinine - blood | Chronic kidney failure | RNA | Parathyroid hormone | Analysis | Cardiac patients | Cytochrome P-450 | Health aspects
Journal Article
Kidney International, ISSN 0085-2538, 01/2011, Volume 79, Issue 1, pp. 112 - 119
We compared the effects of calcitriol and doxercalciferol, in combination with either calcium carbonate or sevelamer, on bone, mineral, and fibroblast growth... 
parathyroid hormone | bone | children | chronic dialysis | FGF-23 | KIDNEY-DISEASE | YOUNG-ADULTS | VITAMIN-D | LINEAR GROWTH | PHOSPHATE BINDER | CALCIUM-CARBONATE | CORONARY-ARTERY CALCIFICATION | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | RENAL OSTEODYSTROPHY | SEVELAMER HYDROCHLORIDE | Polyamines - administration & dosage | Bone and Bones - pathology | Humans | Calcitriol - adverse effects | Ergocalciferols - therapeutic use | Male | Polyamines - therapeutic use | Parathyroid Hormone - blood | Calcitriol - therapeutic use | Bone and Bones - drug effects | Hyperparathyroidism, Secondary - complications | Fibroblast Growth Factors - metabolism | Ergocalciferols - adverse effects | Female | Calcium Carbonate - administration & dosage | Chronic Kidney Disease-Mineral and Bone Disorder - etiology | Sevelamer | Drug Therapy, Combination | Bone Density Conservation Agents - adverse effects | Hyperparathyroidism, Secondary - drug therapy | Osteogenesis - drug effects | Bone Density Conservation Agents - therapeutic use | Calcium Carbonate - therapeutic use | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Bone Density Conservation Agents - pharmacology | Hypercalcemia | Bone and Bones - physiopathology | Calcitriol - pharmacology | Adolescent | Kidney Failure, Chronic - complications | Ergocalciferols - pharmacology | Hyperphosphatemia | Hyperparathyroidism, Secondary - etiology | Longitudinal Studies
Journal Article
Journal Article